JP2024529527A5 - - Google Patents

Info

Publication number
JP2024529527A5
JP2024529527A5 JP2024506443A JP2024506443A JP2024529527A5 JP 2024529527 A5 JP2024529527 A5 JP 2024529527A5 JP 2024506443 A JP2024506443 A JP 2024506443A JP 2024506443 A JP2024506443 A JP 2024506443A JP 2024529527 A5 JP2024529527 A5 JP 2024529527A5
Authority
JP
Japan
Prior art keywords
group
groups
alkyl
halogenated
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506443A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529527A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/110017 external-priority patent/WO2023011539A1/zh
Publication of JP2024529527A publication Critical patent/JP2024529527A/ja
Publication of JP2024529527A5 publication Critical patent/JP2024529527A5/ja
Pending legal-status Critical Current

Links

JP2024506443A 2021-08-04 2022-08-03 シクロアルケン系誘導体調節剤、その製造方法及び応用 Pending JP2024529527A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
CN202110892791.3 2021-08-04
CN202110892791 2021-08-04
CN202111322097.4 2021-11-09
CN202111322097 2021-11-09
CN202210041958.X 2022-01-14
CN202210041958 2022-01-14
CN202210540040 2022-05-17
CN202210540040.X 2022-05-17
PCT/CN2022/110017 WO2023011539A1 (zh) 2021-08-04 2022-08-03 环烯类衍生物调节剂、其制备方法和应用

Publications (2)

Publication Number Publication Date
JP2024529527A JP2024529527A (ja) 2024-08-06
JP2024529527A5 true JP2024529527A5 (https=) 2025-07-31

Family

ID=85155248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506443A Pending JP2024529527A (ja) 2021-08-04 2022-08-03 シクロアルケン系誘導体調節剤、その製造方法及び応用

Country Status (11)

Country Link
US (1) US20240360109A1 (https=)
EP (1) EP4382525A4 (https=)
JP (1) JP2024529527A (https=)
KR (1) KR20240042624A (https=)
CN (1) CN117751110A (https=)
AU (1) AU2022321506A1 (https=)
CA (1) CA3227366A1 (https=)
IL (1) IL310400A (https=)
MX (1) MX2024001331A (https=)
TW (1) TW202321227A (https=)
WO (1) WO2023011539A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3188891A1 (en) 2020-09-01 2022-01-13 Fanglong Yang Fused imidazole derivative, preparation method therefor, and medical use thereof
PT4408840T (pt) 2021-09-27 2025-10-07 Terns Pharmaceuticals Inc Ácidos benzimidazolocarboxílicos como agonistas de glp-1r
CN118401519A (zh) 2021-10-25 2024-07-26 拓臻制药公司 作为glp-1r激动剂的化合物
CN119095843A (zh) 2022-02-23 2024-12-06 拓臻制药公司 作为glp-1r激动剂的化合物
TW202434574A (zh) * 2023-02-02 2024-09-01 大陸商江蘇豪森藥業集團有限公司 一種環烯類化合物的鹽、晶型及其製備方法和應用
EP4568664B1 (en) 2023-04-07 2026-04-01 Terns Pharmaceuticals, Inc. Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating obesity
CN120981457A (zh) 2023-09-14 2025-11-18 歌礼制药(中国)有限公司 Glp-1r激动剂及其治疗方法
TW202521534A (zh) 2023-11-24 2025-06-01 香港商歌禮製藥(中國)有限公司 Glp-1r 激動劑及其治療方法
WO2025247390A1 (zh) * 2024-05-31 2025-12-04 福佑泰生物制药公司 可用作glp-1r激动剂的杂双环化合物
WO2025252201A1 (zh) * 2024-06-07 2025-12-11 江苏豪森药业集团有限公司 一种环烯类衍生物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016022742A1 (en) * 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
KR102314286B1 (ko) * 2016-12-16 2021-10-21 화이자 인코포레이티드 Glp-1 수용체 작용제 및 이의 용도
US10934279B2 (en) * 2018-06-13 2021-03-02 Pfizer Inc. GLP-1 receptor agonists and uses thereof
DK3806855T5 (da) * 2018-06-15 2023-05-22 Pfizer GLP-1-receptoragonister og anvendelser deraf
MA54555A (fr) * 2018-11-22 2021-09-29 Qilu Regor Therapeutics Inc Agonistes de glp-1r et leurs utilisations
EP3953344A4 (en) * 2019-04-12 2023-08-09 Qilu Regor Therapeutics Inc. GLP-IR AGONISTS AND THEIR USES
WO2021018023A1 (zh) * 2019-08-01 2021-02-04 济南泰达领创医药技术有限公司 小分子glp-1受体调节剂
EP4048664A1 (en) * 2019-10-25 2022-08-31 Gilead Sciences, Inc. Glp-1r modulating compounds
WO2021096284A1 (ko) * 2019-11-15 2021-05-20 일동제약(주) Glp-1 수용체 작용제 및 이의 용도
TW202206429A (zh) * 2020-04-29 2022-02-16 美商迦舒布魯姆生物有限公司 雜環glp—1促效劑
CA3192601A1 (en) * 2020-08-21 2022-02-24 Terns Pharmaceuticals, Inc. Compounds as glp-1r agonists
CA3188891A1 (en) * 2020-09-01 2022-01-13 Fanglong Yang Fused imidazole derivative, preparation method therefor, and medical use thereof
EP4229050A4 (en) * 2020-10-13 2024-12-11 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
CN114805336B (zh) * 2021-01-20 2026-04-14 江苏恒瑞医药股份有限公司 稠合咪唑类化合物、其制备方法及其在医药上的应用

Similar Documents

Publication Publication Date Title
JP2024529527A5 (https=)
JP2024523525A5 (https=)
JP2022543767A5 (https=)
JP2023509422A5 (https=)
JP2006502143A5 (https=)
AU2019239955B2 (en) Kv7 channel activators compositions and methods of use
JP2022505525A5 (https=)
JP2011509309A5 (https=)
JP2022510925A5 (https=)
JP2010540508A5 (https=)
JP2023553428A5 (https=)
JP2021522262A5 (https=)
JP2021535112A5 (https=)
RU2017110211A (ru) ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ-ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ
JP2024516033A5 (https=)
JP2021530560A5 (https=)
JP2025503448A5 (https=)
JP2020531454A5 (https=)
JP2023544716A5 (https=)
JP2024528982A5 (https=)
JP2022542140A5 (https=)
JP2024509760A5 (https=)
RU2010136721A (ru) Агонисты мускариновых рецепторов, композиции, способы лечения ими и способы их изготовления
WO2014075618A1 (zh) 含有杂环的5-羟基吲哚类衍生物及其用途
JP2024534572A5 (https=)